Glaukos Corp (GKOS) Q3 2024 Earnings Call Highlights: Record Sales and Raised Guidance Amid ... [Yahoo! Finance]
Glaukos Corporation (GKOS)
Last glaukos corporation earnings: 2/27 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.glaukos.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
US Glaucoma Franchise Sales: $51.6 million, 35% year-over-year growth. International Glaucoma Franchise Sales: $24.5 million, 21% year-over-year growth. Corneal Health Franchise Sales: $20.6 million, 5% year-over-year growth. Photrexa Net Sales: $17.9 million. Convertible Senior Notes Redemption: Notice issued for $57.5 billion principal amount outstanding, due 2027. Warning! GuruFocus has detected 6 Warning Signs with GKOS. Release Date: November 04, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Glaukos Corp ( NYSE:GKOS ) reported record third-quarter consolidated net sales of $96.7 million, marking a 24% increase compared to the previous year. The company raised its full-year 2024 net sales guidance range to $377 million to $379 million, up from the previous range of $370 million to $376 million. Strong performance was driven by both US and international glaucoma franchises, with US glaucoma sales reachi
Show less
Read more
Impact Snapshot
Event Time:
GKOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GKOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GKOS alerts
High impacting Glaukos Corporation news events
Weekly update
A roundup of the hottest topics
GKOS
News
- Ophthalmic Diagnostic Equipment Pipeline Report Featuring Over 205 Companies and Prospective Products by Stages of Development, Segments, Region and Countries, Regulatory Path [Yahoo! Finance]Yahoo! Finance
- Glaukos Co. (NYSE: GKOS) had its price target raised by analysts at Truist Financial Co. from $152.00 to $185.00. They now have a "buy" rating on the stock.MarketBeat
- Glaukos Announces Participation in the J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Glaukos Announces Participation in the J.P. Morgan Healthcare ConferenceBusiness Wire
- Here's Why You Should Add Glaukos Stock to Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
GKOS
Earnings
- 11/4/24 - Beat
GKOS
Sec Filings
- 12/20/24 - Form 144
- 12/20/24 - Form 144
- 12/13/24 - Form 4
- GKOS's page on the SEC website